Daniel K. Nomura was named editor-in-chief of Molecular Cancer Therapeutics, one of the 10 journals published by the American Association for Cancer Research.
Interim analysis of a clinical trial led by Fox Chase Cancer Center researchers shows promise for the treatment of patients with muscle-invasive bladder cancer.